Gait, Parkinson Disease
Conditions
Keywords
Computerized Cognitive training, Quality of life, Gait Function, Executive Function
Brief summary
Parkinson's Disease (PD) is a neurodegenerative, progressive illness. It is a multi-system disease that influences not only the motor but also the cognitive and autonomic systems. The main cognitive impairment in individuals with PD is found in executive function (EF). EF is defined as a set of cognitive skills necessary for planning, monitoring and executing sequences of complex activities. The primary study hypothesis is that computer-based training aimed at improving executive function will have a beneficial effect on gait functions.
Detailed description
Parkinson Disease (PD) is a neurodegenerative, progressive illness. It is a multi-system disease that influences not only the motor but also the cognitive and autonomic systems. The main cognitive impairment in individuals with PD is found in executive function (EF). EF is defined as a set of cognitive skills necessary for planning, monitoring and executing sequences of complex activities. Previous studies have revealed some relation between cognitive states and physical functions in healthy adults. Few studies have examined the effect of computer-based cognitive training on various populations. These studies showed a positive emotional-cognitive effect in those populations. This type of intervention plan was also applied to PD patients. However, there are no reports on the effect of intentional cognitive training on gait functions. The purpose of the study is to assess whether cognitive training, designed to improve EF ability, can also improve gait function in PD patients.
Interventions
OTHERComputerized cognitive training
A 12 week computerized cognitive training at home with the Attengo™ software program.
Sponsors
Tel-Aviv Sourasky Medical Center
Clalit Health Services
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Idiopathic PD. 2. Aged 50-80, living in north region of Israel. 3. Receive regular medications for PD. 4. Not suffering from irregular cognitive disturbance or MMSE\<25. 5. Measured 1-3 on the Hoehn & Yahr scale. 6. Have access to a computer and the ability to operate it.
Exclusion criteria
1. Brain operation, including DBS transplant. 2. History of orthopedic problems that can impair gait (hip/knee fractures and back problems). 3. Orthopedic operation on lower limbs performed no later than six months prior to the beginning of the study. 4. Unbalanced general health: uncontrolled diabetes or blood pressure, etc. 5. Inability to walk independently. 6. Immunodeficiency diseases, active cancer, ischemic diseases. 7. Vision impairment, partial/full blindness. 8. Having participated in similar research or cognitive assessment during the previous year. 9. Have received cognitive or gait training under physical therapy or other programs.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Gait Function | 18 weeks | At enrollment eligible individuals will undergo a thorough baseline assessment using a predefined set of tests and performance measurements. Within a week after enrollment each individual will receive guided training on the use of the intervention tool, the Attengo™ software program. Thereafter they will train at their homes, at least three times a week, for a period of 12 weeks. Follow up assessments will be performed within a week of the end of the training period and 4 weeks thereafter to check for long-term cognitive and motor changes. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Executive function | 18 weeks | At enrollment eligible individuals will undergo a thorough baseline assessment using a predefined set of tests and performance measurements. Within a week after enrollment each individual will receive guided training on the use of the intervention tool, the Attengo™ software program. Thereafter they will train at their homes, at least three times a week, for a period of 12 weeks. Follow up assessments will be performed within a week of the end of the training period and 4 weeks thereafter to check for long-term cognitive and motor changes. |
| Quality of life. | 18 weeks | At enrollment eligible individuals will undergo a thorough baseline assessment using a predefined set of tests and performance measurements. Within a week after enrollment each individual will receive guided training on the use of the intervention tool, the Attengo™ software program. Thereafter they will train at their homes, at least three times a week, for a period of 12 weeks. Follow up assessments will be performed within a week of the end of the training period and 4 weeks thereafter to check for long-run cognitive and motor changes. |
Countries
Israel
Outcome results
None listed